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Summary
TIM (T-cell immunoglobulin (Ig) and mucin domain)-
1, one of the members of TIM family, expresses on
Th2 cells and promotes the production of Th2 signa-
ture cytokines. This can increase a series of responses
in these cells which could be one of the causes of
asthma or asthma-related phenotypes. The aim of this
study was to investigate whether a TIM-1 promoter
single nucleotide polymorphism (SNP), 416 G>C, is
associated with asthma in Iranian population. In this
case–control study, existence of the 416 G>C poly-
morphism was assessed using polymerase chain reac-
tion (PCR) and restriction fragment length
polymorphism (RFLP) in 300 patients with asthma (97
atopic, 203 nonatopic) and 309 healthy volunteers.
Additionally, the relationship between these polymor-
phism genotypes and total serum IgE levels in this Ira-
nian population was evaluated. We discovered a
significant association between the 416 G>C poly-
morphism and atopic asthma susceptibility in the pop-
ulation, but this SNP showed no connection with
nonatopic asthma (P < 0.05). However, our results
showed significant relation between this polymorphism
and serum IgE level (P < 0.05). Our results suggest
that 416 G>C polymorphism in TIM-1 gene could
be a predisposing factor for atopic asthma in Iranian
population, and CC genotype of this SNP can be asso-
ciated with increased level of IgE in patients with
asthma in the same population.
Introduction
Asthma is a serious problem worldwide with an esti-
mated 300 million affected persons (Masoli et al.,
2004; Bateman et al., 2008). Asthma is a chronic
inflammatory disorder of airways resulted from abnor-
mal immune responses and induced by environmental
factors in genetically susceptible individuals (Palmer &
Cookson, 2000). When uncontrolled, could place
severe limitations on life and occasionally could be
fatal (Beasley, 2004; Bateman et al., 2008). It is
proved that CD4+ T helper (Th) 2 cells play crucial
roles in the development of allergen-induced airway
hyper-reactivity (AHR) and in the immunopathogene-
sis of asthma (Mosmann et al., 2005). Activated Th2
cells produce a series of cytokines, including IL-4, IL-5
and IL-10 (Mosmann et al., 1986; Cohn et al., 1997).
Thus, they make B cells to produce antibodies, espe-
cially IgE (Finkelman et al., 1986; Stevens et al.,
1988; Kuhn et al., 1991), which have the ability of
causing asthma and other allergic diseases (Kuchroo
et al., 1995; Hofstra et al., 1998).
Several human linkage analyses have implicated at
least 15 genetic loci in human atopy and asthma, so
far (Steinke et al., 2003; De Souza et al., 2005). One
human genetic area which has received a great deal of
attention is located on 5q23–35. Further analysis iden-
tified a family of similar genes, named TIM, consisting
of three members (TIMs 1, 3 and 4) on human chro-
mosome 5q33.2 (McIntire et al., 2001; Kuchroo et al.,
2003). TIM genes encode surface glycoproteins with
common structural features containing an extracellular
immunoglobulin (Ig)-like domain, a mucin domain
close to the membrane, a single transmembrane
domain, and cytoplasmic regions of various lengths
(Kuchroo et al., 2003; McIntire et al., 2004). On
naive CD4+ T cells, TIM-1 is not expressed (McIntire
et al., 2001; Umetsu et al., 2005), but becomes
upregulated within hours of TCR engagement
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(McIntire et al., 2001), and preferentially expressed on
Th2 cells (Meyers et al., 2005; Umetsu et al., 2005).
Hence, TIM-1 has become a good candidate suscepti-
bility gene for Th2-related diseases, such as asthma (Li
et al., 2006). A number of different population studies
have indicated that the genetic variations in TIM-1
might be associated with susceptibility to allergic dis-
eases (Chae et al., 2003; McIntire et al., 2004; Gao
et al., 2005; Wu et al., 2009).
However, no such correlation has been found in
other populations (Noguchi et al., 2003; Li et al.,
2006). One of these polymorphisms is 416 G>C
which is found to be associated with development of
allergic rhinitis in a Chinese Han population (Mou
et al., 2010), and with asthma susceptibility in the
same population (Liu et al., 2007), while is not corre-
lated 416 G>C with asthma in Korean population
(Chae et al., 2003), but this SNP was associated with
the risk of allergic rhinitis in Mazandaran, Iran
(Hassannia et al., 2011). To determine whether the
416 G>C SNP in TIM-1 promoter is linked with
atopic and nonatopic asthma susceptibility in Iranian
population, we planned a population-based analysis.
We also evaluated the relationship between genotypes
of this polymorphism and total serum IgE levels in
atopic and nonatopic patients with asthma.
Materials and methods
The study was conducted on 300 patients (203 nona-
topic, 97 atopic) offered to Hajar and Amin Hospitals
from Chaharmahal-o Bakhtiari and Isfahan Provinces,
respectively. As controls, we enrolled 309 age-matched
healthy individuals. Controls did not have any of the
symptoms and personal or family history of allergic
and respiratory diseases. All subjects with asthma were
diagnosed according to the GINA (Daraei et al., 2012).
This study is approved by the ethical committee of
the Shahrekord University of Medical Sciences, and
informed consent was obtained from all controls and
patients, and this work was conformed to the provi-
sions of the Declaration of Helsinki (http://
www.ncbi.nlm.nih.gov/pmc/articles/PMC2566407/pdf/
11357217.pdf).
Sample preparation and DNA extraction
Whole-blood samples supplied with EDTA were col-
lected from all subjects. Genomic DNA was extracted
from peripheral blood leucocytes using a Genomic
DNA Isolation Kit (GENET BIO, Korea) according to
the manufacturer’s directions.
PCR ampliﬁcation and sequencing
The genotype of 416 G>C polymorphism was identi-
fied with restriction fragment length polymorphism
(RFLP) method. A 879-bp fragment of TIM1 promoter
was amplified by PCR. The primers used to amplify
the fragment containing the SNP were forward 50- AG
TTGGTTGATTCATATGAGCC-30 and reverse 50-GG
AGGTGTAGTCTGAAGCATG-30. PCR was carried
out in a total volume of 25 lL containing the PCR
mixture of 150 ng genomic DNA, 2.5 lL 109 PCR
buffer, 1 U Taq DNA-polymerase, 200 lmol L1
dNTPs and 400 nmol L1 each primer. Amplification
was performed with an initial denaturation step at
94 °C for 4 min, followed by 35 cycles of denaturation
at 94 °C for 30 s, annealing at 63 for 45 s and
extension at 72 °C for 45 s. A final extension time was
performed at 72 °C for 5 min.
For genotyping the SNP, TaqI restriction enzyme
(Fermentas, Germany) was applied. PCR products
containing the SNP were incubated overnight at 65 °C
with TaqI restriction enzyme according to the manu-
facturer’s instructions. Then, restricted products were
electrophoresed on 1.5% agarose gel and stained with
DNA green viewer and visualized under illumination.
TaqI cut the 879-bp PCR product into two fragments
of 488- and 391-bp length. Fragments 488 bp and
391 bp indicated the presence of homozygous
416GG genotype, a single 879-bp band represented
the presence of homozygous 416CC genotype, and
three fragments of 879 bp, 488 bp and 391 bp dis-
played the presence of heterozygous 416GC (Fig. 1).
The accuracy of the genotyping results was approved
by direct sequencing of several randomly selected sam-
ples to Macrogen Company in Korea.
Statistical analysis
The SPSS 16 software package (SPSS Company, Chi-
cago, IL, USA) was used to carry out statistical analy-
ses. The chi-square test was first applied to compare
the frequency distribution of gender, and smoking sta-
tus between cases and controls and two cases together
groups. In addition, this test was used to compare the
genotype distributions and the allele frequencies
between tree groups. Association between this poly-
morphism and asthma was declared as odds ratios
(OR) estimates with 95% confidence intervals (95%
Figure 1. Genotyping of TIM-1 416 G>C polymorphism by PCR-
RFLP. Lane M: 50-bp DNA marker; Lane C: negative control, lanes 5,
10: homozygous GG, lanes 1, 9: heterozygous GC genotype, lanes 3–
4, 6–8 homozygous CC genotype, Lane 2: PCR; product (undigested).
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CI). Logistic regression analysis was used to predict
the relation of the 416 G>C SNP with susceptibility
to asthma. Furthermore, age, eosinophil percentage
and total serum IgE levels between groups were com-
pared by means of analysis of variance (ANOVA) and
for comparison mean serum IgE levels and eosinophil
percentage. Between genotype groups, ANOVA and
analysis of covariance (ANCOVA) were used. P-value
<0.05 was considered as significant in all of the tests.
Results
In this study, we analysed 416 G>C SNP on TIM-1
gene from 300 patients with asthma (203 nonatopic
and 97 atopic) and 309 healthy controls of an Iranian
population. Selected characteristics of groups are
shown in Table 1. As shown in Table 1, the tree
groups are suitably matched in age and gender. A suc-
cessful genotyping for the SNP was performed (Fig. 1)
and verified by direct sequence analysis. The genotype
distribution in all of the subjects was agreed with
what expected by Hardy–Weinberg equilibrium.
In the atopic patients with asthma, the frequency of
416G/G was higher than C/G and CC genotypes and
C/G genotype was the lowest frequency, and this pat-
tern repeated in nonatopic patients with asthma. In
addition, in atopic patients with asthma, frequencies
of C and G alleles were 36% and 64% and these fre-
quencies in the nonatopic asthma group were 14.8%,
21.2%, 64% and the frequencies of C and G
alleles were 25% and 75%. The multivariate logistic
regression analysis was applied to investigate the asso-
ciation between the 416 G>C polymorphism geno-
types and asthma. However, as indicated in Table 2,
the CC genotype was associated with the risk of atopic
asthma (crude OR = 2.465, 95%, CI = 1.379–4.405,
P = 0.002) but none of the genotypic forms had a pre-
disposing or protective impact on nonatopic asthma
(P > 0.05). Furthermore as shown in Table 3, CC
genotypic forms also had a predisposing effect on ato-
pic asthma after odds ratio (OR) adjustment (adjusted
OR = 0.477, 95%, CI = 0.214–1.063, P = 0.070) and
GG, GC genotypes had no effect on relation to asthma
in any way (Table 2). G allele showed protective effect
against atopic asthma (crude OR = 0.401, 95%,
CI = 0.225–0.715, P = 0.002) but not for nonatopic
asthma (P = 0.302).
Furthermore, the difference of log10 of total serum
IgE level among genotype groups was investigated by
one-way ANOVA test, and a significant difference in
serum IgE level observed among these groups
(Table 4). Bonferroni correction showed that this dif-
ference is related to CC genotype. In other words, CC
genotype has a significant association with total serum
IgE level. After adjusting for variables age, gender and
smoke status, using ANCOVA test, this association sur-
vived (Table 5).
Discussion
In developed countries, atopic diseases such as asthma
are the main causes of morbidity, while their frequency
Table 1. Distributions of the frequency of the selected variables and characteristics of the studied population
Atopic (n = 97)
Nonatopic
(n = 203) Control (n = 309) P-value
Age (mean  SD) 41.37  15.07 43.43  14.44 42.94  14.68 0.518
Gender P a = 0.433
Male 42 (43.3%) 79 (38.9%) 120 (38.8%) P b = 0.985
Female 55 (56/7%) 124 (61.1%) 189 (61.2%) P c = 0.469
Eosinophils (mean  SE) 103per lL 0.31  0.02 0.23  0.02 0.09  0.02 0.000*
Total serum IgE log10 (mean  SD) 2.49  0.30 1.36  0.42 0.77  0.40 0.000*
Smoking P a = 0.918
No 87 (89.7) 183 (90.1%) 276 (89.3%) P b = 0.746
Yes 10 (10.3) 20 (9.9%) 33 (10.7%) P c = 0.902
*P < 0.0001.
aPatients with atopic asthma versus controls; bPatients with nonatopic asthma versus controls; cPatients with atopic asthma versus nonatopic
asthma.
Table 2. Genotype and allele frequencies of
TIM-1 416 G>C polymorphism Atopic
(n/%)
Nonatopic
(n/%)
Control
(n/%)
Crude odds
ratio (95% CI)a P a Pb
Genotype
CC 24 (24.7) 30 (14.8) 36 (11.7) 2.493 (1.399–4.442) 0.002 0.302
GG 52 (53.6) 130 (64) 188 (60.8) 0.744 (0.470–1.178) 0.206 0.466
GC 21 (21.6) 43 (21.2) 85 (27.5) 0.728 (0.423–1.254) 0.252 0.106
aPatients with atopic asthma versus controls; bPatients with nonatopic asthma versus controls.
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has been increasing (Gergen & Weiss, 1992). Asthma
is affected by environmental and genetic factors (Sears
et al., 1991). Several studies have investigated the
association between different TIM-1 polymorphisms
and the risk of various allergic diseases such asthma,
so far (Chae et al., 2003; Gao et al., 2005; Li et al.,
2006; Wu et al., 2009; Mou et al., 2010).
We observed a contradiction in studies about the
association between a SNP in promoter of TIM-1 gene,
416 G>C, and asthma in Korean and Chinese popula-
tion (Chae et al., 2003; Liu et al., 2007). On the other
hand, this polymorphism was associated with allergic
rhinitis; therefore, we suspected this SNP can be linked
with the development of asthma in Iranian population.
In current study, we investigated the frequency of
416 G>C polymorphism among Iranian population
with asthma compared with normal controls, and for
the first time, we examined the correlation of this SNP
with atopic as well as nonatopic asthma. A significant
association was found between the frequency of
416 G>C genotype with atopic asthma in the target
population and CC genotype has predisposing impact
on atopic asthma but none of the CC, GG, GC geno-
types had effect on the risk of non atopic asthma. These
effects also were observed before adjusting for con-
founding effect of variables age, sex and smoking;
hence, we can see lack of the effect of environmental
factors on connection between 416 G>C polymor-
phism and asthma. Moreover, because of the associa-
tion between this polymorphism and atopic asthma
(but not with nonatopic form of the disease), is likely
that this SNP can contribute to asthma susceptibility
through the pathways leading to allergy.
A few studies have investigated for possible con-
nection between 416 G>C and asthma in different
populations, but their findings were contradictory.
Chae et al. have reported that there is no association
between 416 G>C and asthma in Korean popula-
tion (Chae et al., 2003), which is not consistent with
our results. However, our findings are consistent with
the (Liu et al., 2007) report which have shown an
association between 416 G>C and asthma in Chi-
nese Han population. Moreover, our results about
asthma are compatible with the (Hassannia et al.,
2011) findings about allergic rhinitis in an Iranian
population. This harmony with the last study can be
due to the similar genetic background in Iranian pop-
ulation. Overall, these divergent findings in these four
studies may be due to the difference in sample size,
ethnic diversity with particular genetic background
and interaction of distinct environmental factors
which may affect the impact of this polymorphism as
a predisposing factor. We were able to find any
report about the relation of the SNP with atopic and
not with nonatopic in order to compare with our
results, and this report can be due to the relationship
between TIM-1 and atopy.
We also for first time investigated the effect of this
polymorphism on total serum IgE level of patients
with asthma. The results showed that 416 G>C CC
genotype is significantly correlated with increased total
serum IgE level in atopic patient. Based on our survey
in literatures, there was no similar report for compari-
son with this finding. All together, there is a significant
association between 416 G>C and atopic asthma
susceptibility in Iranian population, and this polymor-
phism could be an important factor for increasing the
level of total IgE as one of the important players in
asthma pathogenesis.
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Table 3. Adjusted odds ratios with 95% conﬁdence interval (CI) in
TIM-1 416 G>C genotypes with adjustment for age, gender and
smoke status
Adjusted odds ratios Pa
Groups
CC 2.465 (1.379–4.405) 0.002
GG 0.751 (0.473–1.192) 0.224
GC 0.723 (0.417–1.251) 0.246
aPatients with atopic asthma versus controls.
Table 4. Association between total serum immunoglobulin (Ig) E
levels and Tim-1 416 G>C polymorphism in patients with atopic
asthma
Total serum IgE, log10 values
Mean  SD F P -value
Genotype group
CC 2.089  0.685 11.59 0.000*
GG 1.619  0.606
GC 1.730  0.647
*P < 0.0001.
Table 5. Analysis of covariance of the effect of 416 G>C on total
serum immunoglobulin (Ig) E levels in patients with atopic asthma
after adjustment for age and gender and smoke status
Total serum IgE, log10 values
Mean  SD F P-value
Genotype group
CC 2.089  0.685 11.49 0.000*
GG 1.619  0.606
GC 1.730  0.647
*P < 0.0001.
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